Hyperactive mice show elevated D2High receptors, A model for schizophrenia: Calcium/calmodulin-dependent kinase II alpha knockouts

Synapse

Volumn 64, Issue 10, 2010, Pages 794-800

  Novak, Gabriela ^a   Seeman, Philip ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

AMPA; Animal model; CAMK2B; CaMKII; Dopamine (DA); NMDA; Sensitization; Striatum; Synapse

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE 2 ALPHA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE 2 BETA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DOPAMINE 2 RECEPTOR; MESSENGER RNA; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; FEMALE; FRONTAL CORTEX; HETEROZYGOTE; HYPERACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; BENZYLAMINES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOMPERIDONE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HYPERKINESIS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RATS; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SCHIZOPHRENIA; SULFONAMIDES; TRITIUM;

EID: 77957981997     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20786     Document Type: Article

References (61)

1. Ahmed R, Zha XM, Green SH, Dailey ME. 2006. Synaptic activity and F-actin coordinately regulate CaMKIIalpha localization to dendritic postsynaptic sites in developing hippocampal slices. Mol Cell Neurosci 31:37-51.
2. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE Jr, Jones EG. 1996. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 53:425-436.
3. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR, Lewis DA. 1999. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 156:1580-1589.
4. Benes FM. 2000. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 31(2/3):251-269.
5. Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D. 1998. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach. Synapse 29:142-147.
6. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. 1997. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94:2569-2574.
7. Brocke L, Chiang LW, Wagner PD, Schulman H. 1999. Functional implications of the subunit composition of neuronal CaM kinase II. J Biol Chem 274:22713-22722.
8. Castaneda E, Becker JB, Robinson TE. 1988. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci 42:2447-2456.
9. Cheng Y, Prusoff WH. 1973. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
10. Colbran RJ, Brown AM. 2004. Calcium/calmodulin-dependent protein kinase II and synaptic plasticity. Curr Opin Neurobiol 14:318-327.
11. De Koninck P, Schulman H. 1998. Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science 279:227-230.
12. Derkach V, Barria A, Soderling TR. 1999. Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci USA 96:3269-3274.
13. Douglas RJ. 1967. The hippocarnpus and behavior. Psychol Bull 67:416-422.
14. Dudek SM, Bear MF. 1992. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. Proc Natl Acad Sci USA 89:4363-4367.
15. Elgersma Y, Sweatt JD, Giese KP. 2004. Mouse genetic approaches to investigating calcium/calmodulin-dependent protein kinase II function in plasticity and cognition. J Neurosci 24:8410-8415.
16. Erondu NE, Kennedy MB. 1985. Regional distribution of type II Ca2+/calmodulin-dependent protein kinase in rat brain. J Neurosci 5:3270-3277.
17. Fan GH, Wang LZ, Qiu HC, Ma L, Pei G. 1999. Inhibition of calcium/ calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol Pharmacol 56:39-45.
18. Fink CC, Bayer KU, Myers JW, Ferrell JE Jr, Schulman H, Meyer T. 2003. Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII. Neuron 39:283-297.
19. Fink CC, Meyer T. 2002. Molecular mechanisms of CaMKII activation in neuronal plasticity. Curr Opin Neurobiol 12:293-299.
20. Gardoni F, Mauceri D, Fiorentini C, Bellone C, Missale C, Cattabeni F, Di Luca M. 2003. CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction. J Biol Chem 278:44745-44752.
21. Goldman-Rakic PS. 1996. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 93:13473-13480.
22. Greenstein R, Novak G, Seeman P. 2007. Amphetamine sensitization elevates CaMKIIbeta mRNA. Synapse 61:827-834.
23. Hinds HL, Goussakov I, Nakazawa K, Tonegawa S, Bolshakov VY. 2003. Essential function of alpha-calcium/calmodulin-dependent protein kinase II in neurotransmitter release at a glutamatergic central synapse. Proc Natl Acad Sci USA 100:4275-4280.
24. Hudmon A, Schulman H. 2002a. Neuronal CA21/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71:473-510.
25. Hudmon A, Schulman H. 2002b. Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II. Biochem J 364(Pt 3):593-611.
26. Jones SR, Gainetdinov RR, Wightman RM, Caron MG. 1998. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979-1986.
27. Kantor L, Hewlett GH, Gnegy ME. 1999. Enhanced amphetamineand K+-mediated dopamine release in rat striatum after repeated amphetamine: Differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. J Neurosci 19:3801-3808.
28. Kirov G, O'Donovan MC, Owen MJ. 2005. Finding schizophrenia genes. J Clin Invest 115:1440-1448.
29. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB. 1996. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235-9240.
30. Laruelle M, D'Souza CD, Baldwin RM, Abi-Dargham A, Kanes SJ, Fingado CL, Seibyl JP, Zoghbi SS, Bowers MB, Jatlow P, Charney DS, Innis RB. 1997. Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 17:162-174.
31. Lou L, Zhou T, Wang P, Pei G. 1999. Modulation of Ca2+/calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: Differential regulation of alpha and beta isoforms. Mol Pharmacol 55:557-563.
32. Mayford M, Bach ME, Kandel E. 1996. CaMKII function in the nervous system explored from a genetic perspective. Cold Spring Harb Symp Quant Biol 61:219-224.
33. Mayford M, Wang J, Kandel ER, O'Dell TJ. 1995. CaMKII regulates the frequency-response function of hippocampal synapses for the production of both LTD and LTP. Cell 81:891-904.
34. McGuinness TL, Lai Y, Greengard P. 1985. Ca2+/calmodulin-dependent protein kinase II. Isozymic forms from rat forebrain and cerebellum. J Biol Chem 260:1696-1704.
35. Miller SG, Kennedy MB. 1985. Distinct forebrain and cerebellar isozymes of type II Ca2+/calmodulin-dependent protein kinase associate differently with the postsynaptic density fraction. J Biol Chem 260:9039-9046.
36. Muller D, Oliver M, Lynch G. 1989. Developmental changes in synaptic properties in hippocampus of neonatal rats. Brain Res Dev Brain Res 49:105-114.
37. Novak G, Seeman P, Tallerico T. 2006. Increased expression of calcium/ calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression. Synapse 59:61-68.
38. O'Leary H, Lasda E, Bayer KU. 2006. CaMKII{beta} association with the actin-cytoskeleton is regulated by alternative splicing. Mol Biol Cell 17:4656-4665.
39. Oh JD, Vaughan CL, Chase TN. 1999. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Brain Res 821:433-442.
40. Pierce RC, Kalivas PW. 1997. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci 17:3254-3261.
41. Raiteri M, Cerrito F, Cervoni AM, Levi G. 1979. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208:195-202.
42. Rawls SM, McGinty JF. 2000. Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: An in vivo microdialysis study. Brain Res 861:296-304.
43. Robinson TE, Becker JB. 1982. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur J Pharmacol 85:253-254.
44. Robinson TE, Becker JB, Moore CJ, Castaneda E, Mittleman G. 1985. Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis. Brain Res 343:374-377.
45. Rongo C, Kaplan JM. 1999. CaMKII regulates the density of central glutamatergic synapses in vivo. Nature 402:195-199.
46. Rozen S, Skaletsky HJ. 2000. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics Methods and Protocols: Methods in Molecular Biology. Human Press, Totowa, NJ, pp 365-386.
47. High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity. Synapse 61:573-576.
48. Seeman P, McCormick PN, Kapur S. 2007b. Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO. Synapse 61:263-267.
49. 3H]spiperone in isotonic medium: Implications for human positron emission tomography. Synapse 49:209- 215.
50. Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. 2006. Psychosis pathways converge via D2high dopamine receptors. Synapse 60:319-346.
51. Seeman P, Tallerico T, Ko F, Tenn C, Kapur S. 2002. Amphetaminesensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges. Synapse 46:235-239.
52. Seeman P, Ulpian C, Wreggett KA, Wells J. 1984. Dopamine receptor parameters detected by 3H-spiperone depend on tissue concentration: analysis and examples. J Neurochem 43:221-235.
53. High states, implying many paths to psychosis. Proc Natl Acad Sci USA 102:3513-3518.
54. Shen K, Teruel MN, Subramanian K, Meyer T. 1998. CaMKIIbeta functions as an F-actin targeting module that localizes CaMKIIalpha/ beta heterooligomers to dendritic spines. Neuron 21:593-606.
55. Silva AJ, Paylor R, Wehner JM, Tonegawa S. 1992a. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 257:206-211.
56. Silva AJ, Stevens CF, Tonegawa S, Wang Y. 1992b. Deficient hippocampal long-term potentiation in alpha-calcium- calmodulin kinase II mutant mice [see comments]. Science 257:201-206.
57. Sumiyoshi T, Seeman P, Uehara T, Itoh H, Tsunoda M, Kurachi M. 2005. Increased proportion of high-affinity dopamine D2 receptors in rats with excitotoxic damage of the entorhinal cortex, an animal model of schizophrenia. Brain Res Mol Brain Res 140(1/ 2):116-119.
58. Tan SE. 2002. Impairing the amphetamine conditioning in rats through the inhibition of hippocampal calcium/calmodulin-dependent protein kinase II activity. Neuropharmacology 42:540-547.
59. Thiagarajan TC, Piedras-Renteria ES, Tsien RW. 2002. Alpha- and betaCaMKII. Inverse regulation by neuronal activity and opposing effects on synaptic strength. Neuron 36:1103-1114.
60. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA. 2001. Control of synapse number by glia. Science 291:657-661.
61. Wu GY, Cline HT. 1998. Stabilization of dendritic arbor structure in vivo by CaMKII. Science 279:222-226.